These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 19109042)

  • 1. Predictive factors for the regression of canine transmissible venereal tumor during vincristine therapy.
    Scarpelli KC; Valladão ML; Metze K
    Vet J; 2010 Mar; 183(3):362-3. PubMed ID: 19109042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Canine transmissible venereal tumour: a morphological and immunohistochemical study of 11 tumours in growth phase and during regression after chemotherapy.
    Gonzalez CM; Griffey SM; Naydan DK; Flores E; Cepeda R; Cattaneo G; Madewell BR
    J Comp Pathol; 2000 May; 122(4):241-8. PubMed ID: 10805977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Clinico-pathological study on the effect of vincristine on transmissible venereal tumour in dogs.
    Nak D; Nak Y; Cangul IT; Tuna B
    J Vet Med A Physiol Pathol Clin Med; 2005 Sep; 52(7):366-70. PubMed ID: 16109105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vincristine and ivermectin combination chemotherapy in dogs with natural transmissible venereal tumor of different cyto-morphological patterns: A prospective outcome evaluation.
    Ferreira Bulhosa L; Estrela-Lima A; da Silva Solcà M; Diniz Gonçalves GS; Larangeira DF; de Pinho FA; Barrouin-Melo SM
    Anim Reprod Sci; 2020 May; 216():106358. PubMed ID: 32414469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapeutic management of transmissible venereal tumors in 30 dogs.
    Brown NO; Calvert C; MacEwen EG
    J Am Vet Med Assoc; 1980 May; 176(10 Pt 1):983-6. PubMed ID: 7380719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Canine transmissible venereal tumor: First report of three clinical cases from Tripoli, Libya.
    Hiblu MA; Khabuli NM; Gaja AO
    Open Vet J; 2019 Jul; 9(2):103-105. PubMed ID: 31360646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Semen quality during vincristine treatment in dogs with transmissible venereal tumor.
    Saratsis P; Ypsilantis P; Tselkas K
    Theriogenology; 2000 Mar; 53(5):1185-92. PubMed ID: 10798495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vincristine for treatment of transmissible venereal tumor in the dog--.
    Calvert CA; Leifer CE; MacEwen EG
    J Am Vet Med Assoc; 1982 Jul; 181(2):163-4. PubMed ID: 6749780
    [No Abstract]   [Full Text] [Related]  

  • 9. Transmissible venereal tumor: a retrospective study of 29 cases.
    Rogers KS; Walker MA; Dillon HB
    J Am Anim Hosp Assoc; 1998; 34(6):463-70. PubMed ID: 9826280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination therapy using intratumoral bacillus Calmette-Guerin (BCG) and vincristine in dogs with transmissible venereal tumours: therapeutic efficacy and histological changes.
    Mukaratirwa S; Chitanga S; Chimatira T; Makuleke C; Sayi ST; Bhebhe E
    J S Afr Vet Assoc; 2009 Jun; 80(2):92-6. PubMed ID: 19831270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intratumoral recombinant human interferon alpha-2a and vincristine combination therapy in canine transmissible venereal tumour.
    Kanca H; Tez G; Bal K; Ozen D; Alcigir E; Atalay Vural S
    Vet Med Sci; 2018 Nov; 4(4):364-372. PubMed ID: 30117719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vincristine modulates the expression of Ki67 and apoptosis in naturally occurring canine transmissible venereal tumor (TVT).
    Özalp GR; Zik B; Bastan A; Peker S; Özdemir-Salci ES; Bastan I; Darbaz I; Salar S; Karakas K
    Biotech Histochem; 2012 Jul; 87(5):325-30. PubMed ID: 22404564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-drug chemotherapy of canine transmissible venereal tumor with cyclophosphamide, methotrexate, or vincristine.
    Amber EI; Henderson RA
    J Vet Intern Med; 1992; 6(5):300. PubMed ID: 1432905
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of the multi-drug resistance 1, p53, b cell lymphoma 2, and bcl 2-associated X genes in the biologic behavior and chemotherapeutic resistance of canine transmissible venereal tumors.
    Alzate JM; Montoya-Florez LM; Pérez JE; Rocha NS; Pedraza-Ordonez FJ
    Vet Clin Pathol; 2019 Dec; 48(4):730-739. PubMed ID: 31777108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does the tumour microenvironment alter tumorigenesis and clinical response in transmissible venereal tumour in dogs?
    Ballestero Fêo H; Montoya Flórez L; Yamatogi RS; Prado Duzanski A; Araújo JP; Oliveira RA; Rocha NS
    Vet Comp Oncol; 2018 Sep; 16(3):370-378. PubMed ID: 29508538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-drug chemotherapy of canine transmissible venereal tumor with cyclophosphamide, methotrexate, or vincristine.
    Amber EI; Henderson RA; Adeyanju JB; Gyang EO
    J Vet Intern Med; 1990; 4(3):144-7. PubMed ID: 2366223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Theriogenology question of the month. Transmissible venereal tumor (TVT).
    Hasler AH; Weber WT
    J Am Vet Med Assoc; 2000 May; 216(10):1557-9. PubMed ID: 10825939
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunopathogenic behaviors of canine transmissible venereal tumor in dogs following an immunotherapy using dendritic/tumor cell hybrid.
    Pai CC; Kuo TF; Mao SJ; Chuang TF; Lin CS; Chu RM
    Vet Immunol Immunopathol; 2011 Feb; 139(2-4):187-99. PubMed ID: 21051091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canine transmissible venereal tumour: a review.
    Ganguly B; Das U; Das AK
    Vet Comp Oncol; 2016 Mar; 14(1):1-12. PubMed ID: 23981098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective Treatment of Transmissible Venereal Tumors in Dogs with Vincristine and IL2.
    DEN Otter W; Hack M; Jacobs JJ; Tan JF; Rozendaal L; VAN Moorselaar RJ
    Anticancer Res; 2015 Jun; 35(6):3385-91. PubMed ID: 26026099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.